Pair of Silicon Valley biomeds — Coherus, Nevro — boost IPO plans

The IPO market continues to be choppy but a pair of Silicon Valley companies — Coherus BioSciences and Nevro — have gone ahead and set their price target ranges as they push ahead with plans to go public...